Sotera Health Co
NASDAQ:SHC

Watchlist Manager
Sotera Health Co Logo
Sotera Health Co
NASDAQ:SHC
Watchlist
Price: 15.86 USD 0.19% Market Closed
Market Cap: 4.5B USD
Have any thoughts about
Sotera Health Co?
Write Note

Wall Street
Price Targets

SHC Price Targets Summary
Sotera Health Co

Wall Street analysts forecast SHC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SHC is 17.09 USD with a low forecast of 15.15 USD and a high forecast of 18.9 USD.

Lowest
Price Target
15.15 USD
4% Downside
Average
Price Target
17.09 USD
8% Upside
Highest
Price Target
18.9 USD
19% Upside

SHC Last Price Targets
Sotera Health Co

The latest public price target was made on Nov 6, 2024 by David Windley from Jefferies , who expects SHC stock to rise by 13% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
David Windley
Jefferies
18 USD
Upside 13%
2 days ago
Nov 6, 2024
Sotera Health (SHC) PT Raised to $18 at Jefferies
StreetInsider
Luke Sergott
Barclays
17 USD
Upside 7%
3 months ago
Aug 6, 2024
Sotera Health price target raised to $17 from $14 at Barclays
TheFly
David Windley
Jefferies
14.5 USD
Downside 9%
5 months ago
Jun 6, 2024
Sotera Health (SHC) PT Raised to $14.50 at Jefferies
StreetInsider
Jason Bednar
Piper Sandler
13 USD
Downside 18%
5 months ago
May 21, 2024
Piper Sandler Starts Sotera Health (SHC) at Neutral
StreetInsider
Sean Dodge
RBC Capital
17 USD
Upside 7%
6 months ago
May 3, 2024
Sotera Health (SHC) PT Lowered to $17 at RBC Capital
StreetInsider
Luke Sergott
Barclays
14 USD
Downside 12%
6 months ago
Apr 10, 2024
Sotera Health price target lowered to $14 from $19 at Barclays
TheFly
David Windley
Jefferies
15.5 USD
Downside 2%
7 months ago
Mar 25, 2024
Jefferies Upgrades Sotera Health (SHC) to Buy
StreetInsider
Matthew Mishan
Loop Capital Markets
24 USD
Upside 51%
1 year ago
Jun 26, 2023
Analyst Upgrades Sotera Health Shares To Overweight, Cites Strong Revenue Growth Outlook
Benzinga
Show More Price Targets
Show Less Price Targets
David Windley
Jefferies
Price Target 18 USD
Upside/Downside 13%
View Source
Luke Sergott
Barclays
Price Target 17 USD
Upside/Downside 7%
View Source
David Windley
Jefferies
Price Target 14.5 USD
Upside/Downside 9%
View Source
Jason Bednar
Piper Sandler
Price Target 13 USD
Upside/Downside 18%
View Source
Sean Dodge
RBC Capital
Price Target 17 USD
Upside/Downside 7%
View Source
Luke Sergott
Barclays
Price Target 14 USD
Upside/Downside 12%
View Source
David Windley
Jefferies
Price Target 15.5 USD
Upside/Downside 2%
View Source
Matthew Mishan
Loop Capital Markets
Price Target 24 USD
Upside/Downside 51%
View Source
Show More Price Targets
Show Less Price Targets
Sotera Health Co Competitors:
Price Targets
207940
Samsung Biologics Co Ltd
17% Upside
2268
WuXi XDC Cayman Inc
25% Upside
BIO
Bio Rad Laboratories Inc
5% Upside
STVN
Stevanato Group SpA
18% Upside
TARSONS
Tarsons Products Ltd
32% Upside
RVU
Ryvu Therapeutics SA
90% Upside
OABI
OmniAb Inc
119% Upside
MTD
Mettler-Toledo International Inc
8% Upside

Revenue
Forecast

Revenue Estimate
Sotera Health Co

For the last 4 years the compound annual growth rate for Sotera Health Co's revenue is 8%. The projected CAGR for the next 3 years is 7%.

8%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sotera Health Co

For the last 4 years the compound annual growth rate for Sotera Health Co's operating income is 10%. The projected CAGR for the next 3 years is 29%.

10%
Past Growth
29%
Estimated Growth
Estimates Accuracy
-38%
Average Miss

Net Income
Forecast

Net Income Estimate
Sotera Health Co

The compound annual growth rate of Sotera Health Co's net income for the next 3 years is 76%.

N/A
Past Growth
76%
Estimated Growth
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SHC's stock price target?
Price Target
17.09 USD

According to Wall Street analysts, the average 1-year price target for SHC is 17.09 USD with a low forecast of 15.15 USD and a high forecast of 18.9 USD.

What is Sotera Health Co's Revenue forecast?
Projected CAGR
7%

For the last 4 years the compound annual growth rate for Sotera Health Co's revenue is 8%. The projected CAGR for the next 3 years is 7%.

What is Sotera Health Co's Operating Income forecast?
Projected CAGR
29%

For the last 4 years the compound annual growth rate for Sotera Health Co's operating income is 10%. The projected CAGR for the next 3 years is 29%.

What is Sotera Health Co's Net Income forecast?
Projected CAGR
76%

The compound annual growth rate of Sotera Health Co's net income for the next 3 years is 76%.

Back to Top